2025年6月23日 周一
Home > Archive>Volume 26, Issue 1, 2018 >103-108
PDF HTML XML Export Cite reminder
Overview of lipid metabolism related microRNA
Author:
Affiliation:

1.Department of Anatomy, Yangzhou University, ;2.Department of Neurology, the First People's Hospital of Yangzhou City, Yangzhou, Jiangsu 225000, China)

Clc Number:

Q75

  • Article
    • | |
  • Metrics
    • |
  • Reference [41]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    MicroRNA is an important regulatory factor in the process of gene expression, which plays a very important role in cell differentiation, proliferation, apoptosis and lipid metabolism. Research on microRNA and lipid metabolism has been a hotspot in recent years. The microRNA-33, microRNA-122, microRNA-370, microRNA-758, microRNA-27, microRNA-30c, microRNA-223 and microRNA-144 were mainly involved in the microRNAs related to lipid metabolism. Among them, microRNA-122 and microRNA-33 play a major role in regulating cholesterol and fatty acid balance in vivo. MicroRNAs are involved in the regulation of cell differentiation and lipid metabolism. They are also regulated by transcription factors, adipoc ytokines and environmental factors. Different microRNAs form a complex regulatory network through the regulation of target gene mRNA. This paper reviews the role and the way of microRNA regulation of lipid metabolism.

    Reference
    [1] 汤海渝, 李牧蔚, 高传玉.心血管疾病与表观遗传学研究进展.中华实用诊断与治疗杂志, 6,0(5):426-428.
    [2] 王冬菊.心脑血管疾病流行概况及主要影响因素.预防医学论坛, 6,2(1):71-75.
    [3] Bartel DP.MicroRNAs:target recognition and regulatory functions.Cell, 9,6(2):215-233.
    [4] Bartel DP.MicroRNAs:genomics, biogenesis, mechanism, and function.Cell, 4,6(2):281-297.
    [5] Devaux Y, Zangrando J, Schroen B, et al.Long noncoding RNAs in cardiac development and ageing.Nat Rev Cardiol, 5,2(7):415-425.
    [6] Brennecke J, Stark A, Russell RB, et al.Principles of microRNA-target recognition.PLoS Biol, 5,3(3):e85.
    [7] Doench JG, Sharp PA.Specificity of microRNA target selection in translational repression.Genes Dev, 4,8(5):504-511.
    [8] van Rooij E.The art of microRNA research.Circ Res, 1,8(2):219-234.
    [9] Scherr M, Venturini L, Battmer K, et al.Lentivirus-mediated antagomir expression for specific inhibition of miRNA function.Nucleic Acids Res, 7,5(22):e149.
    [10] Djuranovic S, Nahvi A, Green R.miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay.Science, 2,6(6078):237-240.
    [11] Lagos-Quintana M, Rauhut R, Yalcin A, et al.Identification of tissue-specific microRNAs from mouse.Curr Biol, 2,2(9):735-739.
    [12] Haves CN, Chayama K.MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma.Int J Mol Sci, 6,7(3):280.
    [13] Rayner KJ, Sheedy FJ, Esau CC, et al.Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.J Clin Invest, 1,1(7):2 921-931.
    [14] Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al.Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection.Science, 0,7(5962):198-201.
    [15] Veedu RN, Wengel J.Locked nucleic acid as a novel class of therapeutic agents.RNA Biol, 9,6(3):321-323.
    [16] Esau C, Davis S, Murray SF, et al.miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.Cell Metab, 6,3(2):87-98.
    [17] Gatfield D, Le Martelot G, Vejnar CE, et al.Integration of microRNA miR-122 in hepatic circadian gene expression.Genes Dev, 9,3(11):1 313-326.
    [18] Marquart TJ, Allen RM, Ory DS, et al.miR-33 links SREBP-2 induction to repression of sterol transporters.Proc Natl Acad Sci U S A, 0,7(27):12 228-232.
    [19] Niesor EJ, Schwartz GG, Perez A, et al.Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.Cardiovasc Drugs Ther, 5,9(1):7-14.
    [20] Rayner KJ, Esau CC, Hussain FN, et al.Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.Nature, 1,8(7369):404-407.
    [21] Najafi-Shoushtari SH.MicroRNAs in cardiometabolic disease.Curr Atheroscler Rep, 1,3(3):202-207.
    [22] Fernandez-Hernando C, Suárez Y, Rayner KJ, et al.MicroRNAs in lipid metabolism.Curr Opin Lipidol, 1,2(2):86-92.
    [23] Iliopoulos D, Drosatos K, Hiyama Y, et al.MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism.J Lipid Res, 0,1(6):1 513-523.
    [24] Gao W, He HW, Wang ZM, et al.Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease.Lipids Health Dis, 2,1:55.
    [25] Benatti RO, Melo AM, Borges FO, et al.Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122(miR-122) and microRNA-370 (miR-370) expression in offspring.Br J Nutr, 4,1(12):2 112-122.
    [26] Ramirez CM, Dávalos A, Goedeke L, et al.MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.Arterioscler Thromb Vasc Biol, 1,1(11):2 707-714.
    [27] Mourelatos Z, Dostie J, Paushkin S, et al.miRNPs:a novel class of ribonucleoproteins containing numerous microRNAs.Genes Dev, 2,6(6):720-728.
    [28] Vickers KC, Shoucri BM, Levin MG, et al.MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia.Hepatology, 3,7(2):533-542.
    [29] Chen WJ, Yin K, Zhao GJ, et al.The magic and mystery of microRNA-27 in atherosclerosis.Atherosclerosis, 2,2(2):314-323.
    [30] Vickers KC, Landstreet SR, Levin MG, et al.MicroRNA-223 coordinates cholesterol homeostasis.Proc Natl Acad Sci U S A, 4,1(40):14 518-523.
    [31] Soh J, Iqbal J, Queiroz J, et al.MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion.Nat Med, 3,9(7):892-900.
    [32] Ramirez CM, Rotllan N, Vlassov AV, et al.Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.Circ Res, 3,2(12):1 592-601.
    [33] Wang D, Xia M, Yan X, et al.Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b.Circ Res, 2,1(8):967-981.
    [34] Goedeke L, Rotllan N, Canfrán-Duque A, et al.MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.Nat Med, 5,1(11):1 280-289.
    [35] Hoekstra M, van der Sluis RJ, Kuiper J, et al.Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice.J Nutr Biochem, 2,3(6):622-628.
    [36] Zentz SE, Kurtz CP, Alverson EM.Undergraduate peer-assisted learning in the clinical setting.J Nurs Educ, 4,3(3):S4-S10.
    [37] Mattis AN, Song G, Hitchner K, et al.A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver.Hepatology, 5,1(1):141-152.
    [38] Irani S, Pan X, Peck BC, et al.MicroRNA-30c mimic mitigates hypercholesterolemia and atherosclerosis in mice.J Biol Chem, 6,1(35):18 397-409.
    [39] Keller A, Leidinger P, Borries A, et al.miRNAs in lung cancer-studying complex fingerprints in patient's blood cells by microarray experiments.BMC Cancer, 9,9:353.
    [40] Sun L, Sun S, Zeng S, et al.Expression of circulating microRNA-1 and microRNA-133 in pediatric patients with tachycardia.Mol Med Rep, 5,1(6):4 039-046.
    [41] Ai J, Zhang R, Li Y, et al.Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction.Biochem Biophys Res Commun, 0,1(1):73-77.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

XU Jiang, CHEN Lu, WANG Xiao-Hong, ZHANG Xin-Jiang, LIANG Jing-Yan. Overview of lipid metabolism related microRNA[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(1):103-108.

Copy
Share
Article Metrics
  • Abstract:1005
  • PDF: 1043
  • HTML: 0
  • Cited by: 0
History
  • Received:May 03,2017
  • Revised:September 07,2017
  • Online: February 01,2018
Article QR Code

You are the 65420 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025